MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription

Abstract

Our study provides novel insight into the regulation mechanism of MIG6 and suggests potential implications for the therapeutic strategies of gefitinib resistance through inhibiting MEF2C in hepatic cancer cells.